1Gregory G.Schwartz,Anders G.Olsson,Michael D.Ezekowitz,etal.The Myocardial Ischemia Reduction with Aggressive CholesterolLowering(MIRACL)Trial:Effects of Intensive Atorvastatin Treat-ment on Early Recurrent Events After an Acute Coronary Syn-drome[].Circulation.2000
2Yutaka Furukawa,Ryoji Taniguchi,Natsuhiko Ehara,et al.BetterSurvival With Statin Administration After Revascularization Therapyin Japanese Patients With Coronary Artery Disease-PerspectivesFrom the CREDO-Kyoto Registry[].Circulation Journal.2008
3Ronnie Willenheimer,Dirk J.van Veldhuisen,Bernard Silke,etal.Effect on Survival and Hospitalization of Initiating Treatment forChronic Heart Failure With Bisoprolol Followed by Enalapril,asCompared With the Opposite Sequence:Results of the RandomizedCardiac Insufficiency Bisoprolol Study(CIBIS)Ⅲ[].Circulation.2005
4Marc S.Sabatine,Christopher P.Cannon,C.Michael Gibson,etal.Effect of Clopidogrel Pretreatment Before Percutaneous Coro-nary Intervention in Patients With ST-Elevation Myocardial Infarc-tion Treated With Fibrinolytics:The PCI-CLARITY Study[].The Journal of The American Medical Association.2005
5Warnica WJ,Van Gilst WH,Baillot R,et al.Ischemia managementwith accupril post bypass graft via inhibition of angiotensin conver-ting enzyme(IMAGINE):a multi-center randomized trial-designand rationale[].Canadian Journal of Cardiology.2002
6.Action to Control Cardiovascular Risk in Diabetes Study Group1.Effects of intensive glucose lowering in type 2diabetes[].The New England Journal of Medicine.2008
7Sackett DL,Rosenberg WM,Gray JA,et al.Evidence-based medicine: what is and what it isn’t[].British Medical Journal.1996
8Cannon C P,Braunwald E,McCabe C H,et al.Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes[].The New England Journal of Medicine.2004
9Grundy SM,Cleeman JI,Merz CN,et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines[].Circulation.2004
10Dahlof B,Sever PS,Poulter NR, et al.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-B[].LancetThe.2005
